Laboratory diagnosis of variant Creutzfeldt-Jakob disease

Histopathology

Volumn 37, Issue 1, 2000, Pages 1-9

  Ironside, J W ^a,b   Head, M W ^a   Bell, J E ^a   McCardle, L ^a   Will, R G ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Creutzfeldt Jakob disease; Diagnosis; Neuropathology; Prion protein; Variant CJD

Indexed keywords

PRION PROTEIN;

AUTOPSY; BIOCHEMISTRY; CENTRAL NERVOUS SYSTEM; CODON; CREUTZFELDT JAKOB DISEASE; FROZEN SECTION; HUMAN; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; LABORATORY DIAGNOSIS; LYMPHOID TISSUE; MORPHOLOGY; NEUROPATHOLOGY; NONHUMAN; PRION; PRIORITY JOURNAL; REVIEW; VIRUS GENE;

BLOTTING, WESTERN; BRAIN; CREUTZFELDT-JAKOB SYNDROME; GREAT BRITAIN; HUMANS; IMMUNOHISTOCHEMISTRY; LABORATORY TECHNIQUES AND PROCEDURES; PRPSC PROTEINS;

EID: 0033930868     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2000.00946.x     Document Type: Review

References (29)

1. 1. Will RG, Ironside JW, Zeidler M et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347; 921-925.
2. 2. Bruce ME, Will RG, Ironside JW et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997; 389; 498-501.
3. 3. Hill AF, Desbruslais M, Joiner S, Sidle KCL, Gowland I, Collinge J. The same prion strain causes vCJD and BSE. Nature 1997; 389; 448-450.
4. 4. World Health Organisation. Report of a WHO, consultation on clinical and neuropathological characteristics of the new variant of CJD, other human and animal transmissible spongiform encephalopathies. Geneva: World Health Organisation, 1996.
5. 5. Bell JE, Gentleman SM, Ironside JW et al. Prion protein immunocytochemistry - UK five centre consensus report. Neuropathol. Appl. Neurobiol. 1997; 23; 26-35.
6. 6. MacDonald ST, Sutherland K, Ironside JW. Prion protein genotype and pathological phenotype studies in sporadic Creutzfeldt-Jakob disease. Neuropathol. Appl. Neurobiol. 1996; 22; 285-292.
7. 7. Collinge J, Sidle KCL, Meads J, Ironside JW, Hill AF. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996; 383; 685-690.
8. 8. Ironside JW. New-variant Creutzfeldt-Jakob disease. Neuropathology 1998; 18; 131-138.
9. 9. Ironside JW, Sutherland K, Bell JE et al. A new variant of Creutzfeldt-Jakob disease: neuropathological and clinical features. Cold Spring Harbor Symposium Quant. Biol. 1996; LXI; 523-530.
10. 10. Hilton DA, Fathers E, Edwards P, Ironside JW, Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1999; 352; 703-704.
11. 11. Hill AF, Butterworth RJ, Joiner S et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999; 353; 183-189.
12. 12. Parchi P, Capellari S, Chen SG et al. Typing prion isoforms. Nature 1997; 386; 232-233.
13. 13. Parchi P, Giese A, Capellari S et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 1999; 46; 224-233.
14. 14. Britton TC, Al-Sarraj S, Shaw C, Campbell T, Collinge J. Sporadic Creutzfeldt-Jakob disease in a 16-year-old in the UK. Lancet 1995; 346; 1155.
15. 15. Bateman D, Hilton D, Love S, Zeidler M, Beck J, Collinge J. Sporadic Creutzfeldt-Jakob disease in a 18-year-old in the UK. Lancet 1995; 346; 1155-1156.
16. 16. Will RG, Alperovitch A, Poser S et al. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries. 1993-95. Ann. Neurol. 1998; 43; 763-767.
17. 17. Fraser H. The pathogenesis of pathology of scrapie. In: Tyrell DAJ, eds. Aspects of Slow and Persistent Virus Infections. The Hague: Martinus-Nijhoff, 1979: 30-58.
18. 18. Williams ES, Young S. Neuropathology of chronic wasting disease of mule deer (odocoileus hemionus) and elk (Cervus elaphus nelsoni). Vet. Pathol. 1993; 30; 36-45.
19. 19. Lasmézas CI, Ironside JW, Chiach C et al. BSE transmission to macaques. Nature 1996; 381; 743-744.
20. 20. Shimizu S, Hoshi K, Muramoto T et al. Creutzfeldt-Jakob disease with florid-type plaques after cadaveric dura mater grafting. Arch. Neurol. 1999; 56; 357-363.
21. 21. Schoene WC, Masters CL, Gibbs CJ Jr. et al. Transmissible spongiform encephalopathy (Creutzfeldt-Jakob disease). Atypical clinical and pathological findings. Ann. Neurol. 1981; 38; 473-477.
22. 22. McLean CA, Ironside JW, Masters CL. Comparative neuropathology in kuru and new variant CJD. Brain Pathol. 1997; 7; 1247-1248.
23. 23. Ironside JW. Prion diseases in man. J. Pathol. 1998; 186; 227-234.
24. 24. Gambetti P, Parchi P, Petersen RB, Chen SG, Lugaresi E. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features. Brain Pathol. 1995; 5; 43-51.
25. 25. Mastrianni JA, Nixon R, Layzer R et al. Prion protein conformation in a patient with sporadic fatal insomnia. New Engl. Med. J. 1999; 340; 1630-1638.
26. 26. Cervenakova L, Goldfarb LG, Garruto R, Lee H-S, Gajdusek DC, Brown P. Phenotype-genotype studies in kuru: implications for new variant Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. USA 1999; 95; 13239-13241.
27. 27. Parchi P, Castellani R, Cortelli P et al. Regional distribution of protease-resistant prion protein in fatal familial insomnia. Ann. Neurol. 1995; 38; 21-29.
28. 28. Telling GC, Parchi P, DeArmond SJ et al. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996; 274; 2079-2082.
29. 29. Parchi P, Chen SG, Brown P et al. Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Straussler-Scheinker disease. Proc. Natl. Acad. Sci. USA 1999; 95; 8322-8327.